Moneycontrol
HomeNewsBusinessCentre’s decision on IBC may impact homebuyers’ interests: Experts
Trending Topics

Centre’s decision on IBC may impact homebuyers’ interests: Experts

The extension unlikely to impact ongoing cases. However, delivery of homes may get delayed and buyers may not be able to initiate corporate insolvency resolution process (CIRP) in case of fresh matters

September 25, 2020 / 14:46 IST
Story continues below Advertisement

The government, on September 24, decided to provide some "breathing time" for companies to recover from coronavirus pandemic-induced financial stress and extended the suspension of fresh insolvency proceedings under the insolvency law by three months until December 25.

This, say some legal experts, will adversely affect homebuyers’ interests as delivery of homes may get delayed and they may not be able to initiate the corporate insolvency resolution process (CIRP).

Story continues below Advertisement

“The will provide a window to the errant builders to take the homebuyer for granted. The homebuyer who was earlier categorised as a financial creditor and could have initiated corporate insolvency under section 7 of IBC 2016, was earlier hit by an amendment wherein 10 percent of the total allottees or 100 allottees (whichever was less) were required to initiate the CIRP against the builder,” Sumit Batra, Partner at India Law Alliance, a law firm told Moneycontrol.

“With extensions as are being provided now, the homebuyer will suffer the maximum as neither he would be able to get his dream home nor he would be able to initiate CIRP,” he said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show